Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jan;42(1):95-97.
doi: 10.1007/s40264-018-0766-8.

Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records

Affiliations
Editorial

Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records

Feifan Liu et al. Drug Saf. 2019 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Feifan Liu has no conflicts of interest that are directly relevant to the content of this study.

Abhyuday Jagannatha has no conflicts of interest that are directly relevant to the content of this study.

Hong Yu has no conflicts of interest that are directly relevant to the content of this study.

References

    1. Jeetu G, Anusha G. Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring. J Young Pharm 2010;2:315–20. - PMC - PubMed
    1. Coloma PM, Trifirò G, Patadia V, Sturkenboom M. Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture? Drug Saf 2013;36:183–97. - PubMed
    1. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. JAMA: the journal of the American Medical Association 1997;277:307. - PubMed
    1. Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005;165:1111–6. - PubMed
    1. Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis. PLoS ONE 2012;7:e33236. - PMC - PubMed

Publication types

MeSH terms